Plica Vaccines Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
- Paid Up Capital ₹ 19.50 Cr
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 2344.00%
- Profit Growth -18.03%
- Ebitda 1.07%
- Net Worth 1029.73%
- Total Assets 18.58%
About Plica Vaccines
Plica Vaccines Private Limited (PVPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 June 2021 (Three years and seven months 13 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 19.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Plica Vaccines Private Limited India is Deepa Singhal as COMPANY SECRETARY. Vikas Agarwal, Shveta Agarwal, and Ved Prakash serve as directors at the Company.
Company Details
-
Location
Ghaziabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299UP2021PTC147827
-
Company No.
147827
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Jun 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Plica Vaccines?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Agarwal
|
Managing Director | 26-Jun-2021 | Current |
| Deepa Singhal | Company Secretary | 13-Oct-2023 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Shveta Agarwal
|
Whole-Time Director | 26-Jun-2021 | Current |
|
Ved Prakash
|
Whole-Time Director | 26-Jun-2021 | Current |
Financial Performance of Plica Vaccines.
Plica Vaccines Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 2344% increase. The company also saw a substantial fall in profitability, with a 18.03% decrease in profit. The company's net worth Soared by an impressive increase of 1029.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plica Vaccines?
In 2024, Plica Vaccines had a promoter holding of 99.77% and a public holding of 0.23%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Harmony Agrotech Private LimitedVikas Agarwal and Ved Prakash are mutual person
-
Plica India Private Limited
Vikas Agarwal, Shveta Agarwal and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Plica Vaccines?
Plica Vaccines has a workforce of 24 employees as of Dec 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plica Vaccines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plica Vaccines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.